Anandenanthera colubrina (Vell.) Brenan as an inhibitor of HIV-1 BaL infection

Nat Prod Res. 2022 Mar;36(6):1621-1625. doi: 10.1080/14786419.2021.1892097. Epub 2021 Mar 17.

Abstract

We reported the in vitro anti-HIV-1 activity, cytotoxicity, cytokines expression and chemical profile of Anadenanthera colubrina. Cytotoxicity was evaluated on TZM-bl, HL2/3 cells and macrophages. Anti-HIV-1 activity was determined by Luciferase assay (TZM-bl cells) and by HIV-p24 quantification (macrophages) assessed by ELISA. TZM-bl and HL2/3 cells were used to determine cell-cell fusion inhibition. Cytokines expression was assessed by ELISA. Chemical composition was determined by Gas Chromatography Coupled to Mass Spectrometry. At 66.6 µg/mL, the extract maintained the cell viability above 90%. At 33.28 µg/mL, the extract reduced 82.8% of HIV-1 infection (TZM-bl cells) and HIV-p24 expression (macrophages). The extract inhibited approximately 70% of TZM-bl and HL2/3 cells fusion. Extract did't induce inflammatory response. Phytochemical analysis showed presence of flavonoid, phenolic acids, fatty acids and sugars. This is the first study presenting the anti-HIV effect of A. colubrina, showing low cytotoxicity and no inflammatory stimuli, important requirements for a microbicide development.

Keywords: HIV infection; anti-HIV agents; medicinal plants; microbicides; natural products.

MeSH terms

  • Colubrina*
  • Gas Chromatography-Mass Spectrometry
  • HIV Infections*
  • HIV-1*
  • Humans
  • Plant Extracts / pharmacology

Substances

  • Plant Extracts